The outlook issued last Aug was "Targeting FY19 revenue of approx $260m and EBITDA of approx $36m"
Then at the AGM they stated revenue was ahead of budget, but operating costs were ~30%, against target 26%.
The strategic review announcement has added further uncertainty and caution.
So there is a certain level of downgrade already built into the current share price.
I don't expect the announcement is related to a goodwill impairment, as that would not impact on EBITDA.
The outlook issued last Aug was "Targeting FY19 revenue of...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $662.1M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 40.0¢ | 39.0¢ | $175.9K | 447.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 651371 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 855032 | 7 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PGC (ASX) Chart |